Inflammation and neurovascular changes in amyotrophic lateral sclerosis.

Neuroinflammation in now established as an important factor in the pathogenesis of many neurodegenerative diseases, including amyotrophic lateral sclerosis (ALS). At various time points, astrocytes and microglia are markedly activated, either producing neuroprotective or pro-inflammatory molecules,...

Cijeli opis

Bibliografski detalji
Glavni autori: Evans, M, Couch, Y, Sibson, N, Turner, M
Format: Journal article
Jezik:English
Izdano: 2013
_version_ 1826276529775050752
author Evans, M
Couch, Y
Sibson, N
Turner, M
author_facet Evans, M
Couch, Y
Sibson, N
Turner, M
author_sort Evans, M
collection OXFORD
description Neuroinflammation in now established as an important factor in the pathogenesis of many neurodegenerative diseases, including amyotrophic lateral sclerosis (ALS). At various time points, astrocytes and microglia are markedly activated, either producing neuroprotective or pro-inflammatory molecules, which can decrease or increase the rate of primary motor neuron degeneration respectively. Recent research has shown that this neuroinflammatory component is affected by the peripheral immune system; T lymphocytes in particular are able to cross into the brain and spinal cord parenchyma, where they interact with resident microglia, either inducing them to adopt an M1 (cytotoxic) or M2 (protective) phenotype, depending on the stage of disease. Clearly understanding the changes that occur to allow the interaction between peripheral and central immune responses will be essential in any attempt to manipulate the disease process via neuroinflammatory mechanisms. However, our understanding of the endothelial changes, which facilitate the infiltration of peripheral immune cells into the brain and spinal cord, is still in its infancy. There are suggestions, though, of up-regulation of cellular adhesion molecules, which are able to arrest circulating leukocytes and facilitate diapedesis into the brain parenchyma. In addition, tight junction proteins appear to be down-regulated, leading to an increase in vascular permeability, an effect that is amplified by vascular damage late in the disease process. This review summarises our current knowledge regarding neuroinflammation, peripheral immune involvement, and endothelial changes in ALS. This article is part of a Special Issue entitled 'Neuroinflammation in neurodegeneration and neurodysfunction'.
first_indexed 2024-03-06T23:15:20Z
format Journal article
id oxford-uuid:66f11327-e3a3-41bd-9ddf-db3e71771ca6
institution University of Oxford
language English
last_indexed 2024-03-06T23:15:20Z
publishDate 2013
record_format dspace
spelling oxford-uuid:66f11327-e3a3-41bd-9ddf-db3e71771ca62022-03-26T18:34:58ZInflammation and neurovascular changes in amyotrophic lateral sclerosis.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:66f11327-e3a3-41bd-9ddf-db3e71771ca6EnglishSymplectic Elements at Oxford2013Evans, MCouch, YSibson, NTurner, MNeuroinflammation in now established as an important factor in the pathogenesis of many neurodegenerative diseases, including amyotrophic lateral sclerosis (ALS). At various time points, astrocytes and microglia are markedly activated, either producing neuroprotective or pro-inflammatory molecules, which can decrease or increase the rate of primary motor neuron degeneration respectively. Recent research has shown that this neuroinflammatory component is affected by the peripheral immune system; T lymphocytes in particular are able to cross into the brain and spinal cord parenchyma, where they interact with resident microglia, either inducing them to adopt an M1 (cytotoxic) or M2 (protective) phenotype, depending on the stage of disease. Clearly understanding the changes that occur to allow the interaction between peripheral and central immune responses will be essential in any attempt to manipulate the disease process via neuroinflammatory mechanisms. However, our understanding of the endothelial changes, which facilitate the infiltration of peripheral immune cells into the brain and spinal cord, is still in its infancy. There are suggestions, though, of up-regulation of cellular adhesion molecules, which are able to arrest circulating leukocytes and facilitate diapedesis into the brain parenchyma. In addition, tight junction proteins appear to be down-regulated, leading to an increase in vascular permeability, an effect that is amplified by vascular damage late in the disease process. This review summarises our current knowledge regarding neuroinflammation, peripheral immune involvement, and endothelial changes in ALS. This article is part of a Special Issue entitled 'Neuroinflammation in neurodegeneration and neurodysfunction'.
spellingShingle Evans, M
Couch, Y
Sibson, N
Turner, M
Inflammation and neurovascular changes in amyotrophic lateral sclerosis.
title Inflammation and neurovascular changes in amyotrophic lateral sclerosis.
title_full Inflammation and neurovascular changes in amyotrophic lateral sclerosis.
title_fullStr Inflammation and neurovascular changes in amyotrophic lateral sclerosis.
title_full_unstemmed Inflammation and neurovascular changes in amyotrophic lateral sclerosis.
title_short Inflammation and neurovascular changes in amyotrophic lateral sclerosis.
title_sort inflammation and neurovascular changes in amyotrophic lateral sclerosis
work_keys_str_mv AT evansm inflammationandneurovascularchangesinamyotrophiclateralsclerosis
AT couchy inflammationandneurovascularchangesinamyotrophiclateralsclerosis
AT sibsonn inflammationandneurovascularchangesinamyotrophiclateralsclerosis
AT turnerm inflammationandneurovascularchangesinamyotrophiclateralsclerosis